| Stem cell treatments in neurology from the clinician viewpoint | Aksel SİVA | 321–324 |
| Stem cell transplantation in multiple sclerosis: Experiences, questions and problems | Gülçin BENBİR, Ayşe ALTINRAŞ | 325–336 |
| Neurodegenerative disorders with brain iron accumulation | Güneş KIZILTAN, Cengiz YALÇINKAYA, Gülçin BENBİR | 337–357 |
| Molecular analysis of exon 7 and 8 of SMN gene in spinal muscular atrophy patients | Ali İrfan GÜZEL, Filiz KOÇ, Özlem HERGÜNER, Halil KASAP, Yakup SARICA, Kocatürk Sabriye SEL | 353–361 |
| Long-term prognosis and factors influencing prognosis in 20 patients with certebral venous thrombosis: Combined analysis of 582 patients | Talip ASİL, Ufuk UTKU, Kemal BALCI | 362–366 |
| Ischemic cerebellar stroke: Magnetic resonance imaging and magnetic resonance angiography study | Cem ÇALLI, Nilgün YÜNTEN, Emre KUMRAL, Ayşe SAĞDUYU, Ataç Ceyla UÇAR, Figen GÖKÇAY, Çağla KAYA, Hadiye ŞİRİN | 367–376 |
| The relationship between EEG findings and prognosis in patients with metabolic encephalopathies | Kezban ASLAN, Yakup SARICA, Nida TAŞÇILAR, Hacer BOZDEMİR | 377–384 |
| Ergotamine tartrate in migraine attack and tolerance development | Hulusi KEÇECİ, Yıldız DEĞİRMENCİ | 385–390 |
| Tumefactive multiple sclerosis: Case report and review of the literature | Deniz YERDELEN, Semih GİRAY, Başak KARAKURUM, Sibel KARACA, Sibel BENLİ, Mehmet KARATAŞ | 391–397 |